United States · FDA National Drug Code directory
lamivudine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 31722-001_2b449c4a-56db-0d5f-e063-6394a90ad576
- Product NDC
- 31722-001
- Form
- TABLET, FILM COATED
- Composition / generic term
- lamivudine
- Labeler
- Camber Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190321
- Source listing expiry
- 20261231
Source-listed ingredients
- LAMIVUDINE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 20 BLISTER PACK in 1 CARTON (31722-001-02) / 10 TABLET, FILM COATED in 1 BLISTER PACK · 31722-001-02
- 60 TABLET, FILM COATED in 1 BOTTLE (31722-001-60) · 31722-001-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →